Page 9 - Radcom Network Insights News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Radcom network insights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Radcom Network Insights Today - Breaking & Trending Today

RADCOM (NASDAQ:RDCM) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of RADCOM (NASDAQ:RDCM – Free Report) in a research note issued to investors on Friday morning. The firm issued a buy rating on the technology company’s stock. RADCOM Trading Down 0.3 % RADCOM stock opened at $8.66 on Friday. RADCOM has a 12 month low of $8.36 and a 12 […] ....

Service Assurance , Jpmorgan Chase Co , Network Insights , Company Profile , Network Visibility , Renaissance Technologies , Acadian Asset Management , Janney Montgomery Scott , Millennium Management , Free Report , Get Free Report , Montgomery Scott , Asset Management , Nasdaq Rdcm , Computer And Technology , Initiated Coverage , Stocknews Com ,

Adcom leaves Brainstorm looking at options

Brainstorm Cell Therapeutics Inc. said it’s exploring all its options in the wake of a Sept. 27 U.S. FDA advisory committee vote, in which the committee overwhelmingly disagreed with the company that the data it presented supported the effectiveness of Nurown (debamestrocel) for the treatment of mild to moderate amyotrophic lateral sclerosis. ....

Brainstorm Cell Therapeutics Inc , Brainstorm Cell Therapeutics , Brainstorm Cell Therapeutics Inc , Amyotrophic Lateral Sclerosis , Stem Cells ,

US FDA flexibility the question as Nurown goes before adcom

How flexible should the U.S. FDA evidentiary standards be for a therapy addressing a significant unmet need in a disease such as amyotrophic lateral sclerosis (ALS)? That’s the question the agency’s Cellular, Tissue and Gene Therapies Advisory Committee will ponder Sept. 27 as it looks at the data for Brainstorm Cell Therapuetics Inc.’s Nurown (debamestrocel), a mesenchymal stromal cell therapy targeting ALS. ....

Brainstorm Cell Therapuetics Inc , Gene Therapies Advisory Committee , Brainstorm Cell Therapuetics , Amyotrophic Lateral Sclerosis , Brainstorm Cell Therapeutics Inc , Biogen Inc , Ionis Pharmaceuticals Inc ,

Head to Head Contrast: Pioneer Bankshares (OTCMKTS:PNBI) and Dime Community Bancshares (NASDAQ:DCOM)

Dime Community Bancshares (NASDAQ:DCOM – Get Free Report) and Pioneer Bankshares (OTCMKTS:PNBI – Get Free Report) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership. Analyst Recommendations This is a breakdown […] ....

New York , United States , News Ratings For Dime Community Bancshares Daily , Pioneer Bank Inc , Given Dime Community Bancshare , Home Loan Bank , Dime Community Bancshares , Dime Community Bank , National Mortgage Association , Pioneer Bankshares Inc , Dime Community Bancshares Inc , Government National Mortgage Association , Federal Home Loan Mortgage Corporation , Home Loan Mortgage Corporation , Federal National Mortgage Association , Get Free Report , Pioneer Bankshares , Community Bancshares , Pioneer Bankshare , Federal Home Loan Bank , Pioneer Bank , Dime Community Bancshares Daily , Nasdaq Dcom , Stock Comparison , Stock Analysis ,